论文部分内容阅读
小剂量米非司酮序贯合并前列腺素已被大量临床研究证实为安全有效的非手术终止早孕方法。目前在我国抗早孕配伍方法的使用过程中:米非司酮150mg分次或200mg顿服,配伍卡孕栓1mg;对于放置卡孕栓1mg,个别接受者有腹痛、腹泻的副反应,且卡孕栓价格也较昂贵。为此,设计了米非司酮配伍小剂量卡前列甲酯栓(卡孕栓)抗早孕的研究,经预试验后进行了4个临床观察中心的研究,现将
Small doses of mifepristone sequential combination of prostaglandin has been confirmed by a large number of clinical studies for the safe and effective non-surgical termination of early pregnancy method. Currently in our country the use of anti-early pregnancy compatibility method: mifepristone 150mg or 200mg sub-sub-Dayton, compatibility with caesarean suppository 1mg; for placement of carboplatin 1mg, individual recipients have abdominal pain, diarrhea side effects, and the card Pregnancy suppository prices are also more expensive. To this end, the design of mifepristone with low-dose card forefront of methyl ester suppository (carboplatin suppository) anti-pregnancy study, after the pre-test conducted four clinical observation center research, will